Navigation Links
ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
Date:10/25/2008

CTEMRA, may cause an increase in the risk of malignancies.

About IL-6

IL-6 is a common protein found in all joints in the body and is a natural substance that can raise inflammation. Everyone has IL-6 in their body, but people with RA may have too much. When approved, ACTEMRA will be the first and only medication to specifically target IL-6 in patients with RA.

About Rheumatoid Arthritis

Rheumatoid arthritis is a progressive, systemic autoimmune disease characterized by inflammation of the membrane lining in the joints. This inflammation causes a loss of joint shape and function, resulting in pain, stiffness and swelling, ultimately leading to irreversible joint destruction and disability. Characteristics of RA include redness, swelling, pain and movement limitation around joints of the hands, feet, elbows, knees and neck that leads to loss of function. In addition, the systemic symptoms of RA include fatigue, decreased hemoglobin, osteoporosis and may contribute to shortening life expectancy by affecting major organ systems. After 10 years, less than 50 percent of patients can continue to work or function normally on a daily basis. RA affects more than 21 million people worldwide with approximately 1.3 million adults affected in the United States.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been n
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
2. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
3. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
4. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
5. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
6. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
7. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
8. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
9. Hibernation-On-Demand Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
10. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
11. New Study: Pine Bark Significantly Reduces Menstrual Pain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...K,Calif.,Nov.25/PRNewswire/--PraxisElectronicMedic...ademyofFamilyPhysicians,(AAFP)FamilyPracticeManage...medicalquality,healthmaintenance,anddiseasemanagem...salsoranked#1amongdoctorsindicatingtheirEMRhadapos...alsorankednumberoneinthecountryinprovidingexcellen...
(Date:11/25/2009)...HIA,Nov.25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES...ny,sPresidentandCEO,andKeithSchneck,theCompany,sEx...the21stAnnualPiperJaffrayHealthCareConferenceat1:3... Interestedpartiesmayaccessthepresentationbyvisiti...m .Thewebcastmayalsobeaccessedat http://www.corpor...
(Date:11/25/2009)...RK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTech...oamthatstopsseverebleeding,wonfirstprizeand$10,000...ecurityChallenge2009,companyofficialsannouncetoday...eworld,Remedium,steampitchedtheirinventionattheGSC...iness. ,, Remedium( www.remediumtechnologies.co...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Key to evolutionary fitness 3A Cut the calories 9078 1Key to evolutionary fitness 3A Cut the calories 9078 2First step to converting solar energy using artificial leaf 12859 1First step to converting solar energy using artificial leaf 12859 2Specialized California Medical Center 28Heart411 com 29 Offers Top Notch Cardiothoracic Surgery 50474 1Specialized California Medical Center 28Heart411 com 29 Offers Top Notch Cardiothoracic Surgery 50474 2
... Md., April 27 As body mass increases, so does ... according to Baltimore researchers. A new study, ...f the American Urological Association (AUA), asses...luated insurance claims of 95,962 subjects over a ...ify whether obesity is associated with a UTI diagn...
... Build on Pivotal Phase III Study for the Treatmen...., April 27 Ferring Pharmaceuticals announced tod...garelix for injection, a new injectable gonadotrop...proved by the U.S. Food and Drug Administration (F...d prostate cancer. The announcement was made at...
Other Medicine Technology:Obesity Associated With Higher Risk for Urinary Tract Infections 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5
(Date:11/27/2009)...ire-FirstCall/--ShamirOpticalIndustryLtd.(Nasdaq: ...ductsandtechnologytotheophthalmiclensmarket,announ...ddistributioninanaggregateamountofUS$10million(app...representativerateofexchange),orapproximatelyUS$0....presentativerateofexchange)perordinarysharebasedon...
(Date:11/27/2009)...de; announced today that Spectrum Health (Grand Ra...ise orthopedic templating solution and its TraumaC... (PRWEB) November 27, 2009 -- Voyant Health&t...Rapids, Michigan) has licensed its TraumaCad Enter...aCad Extend workflow solution, to allow its orthop...
(Date:11/26/2009)...ThediabetespopulationintheUnitedStateswillalmostdo...ediseaseisprojectedtohit$336billion,upfrom$113bill...sueof DiabetesCare .TheNational ChangingDiabetes &...nedtheanalysisbyateamfromtheUniversityofChicago. ,...vingwithdiabeteswillrisefrom23.7millionin2009to44....
(Date:11/26/2009)...rom the North Pole, Textsanta.net lets parents sig... North Pole, AK (PRWEB) -- ...at the North Pole Santa Claus has added SMS text m...informed of his Christmas progress at the North Po... have identified a large and growing percentage of...
(Date:11/25/2009)...swire/--WhenmostpeopleheartheacronymTMJ,theythinko...hehelptheyneed.TMJstandsfortheTemporal-MandibularJ...swithyourskull(temporalbone). ,, Themostcommons...ing,clickingorpoppingofthejaw.Butmanyothersymptoms...atigue,sleepdisturbances,irritability,alossinfocus...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...4 As Congress begins its first term and the Obama...ican Public Health Association (APHA) urges our el...c health as the foundation for a strong national h...nistration to ensure that each individual has acce...
..., Jan. 14 A special series of papers in the pee...rehensive look at future directions of research on...h advance the scientific understanding of the gene... are available online at www.liebertpub.com/zeb ...
...uary 14, 2009 - A new study suggests that adult bo...on of artificial skin. The findings mark an advanc...a method of organ reconstruction. The study is pub...cial Organs (INFA) and the International Society f...
...an. 14 A surge of arctic air forecast to arrive i...nd chills that could lead to serious health proble...eratures across Pennsylvania are expected to range...reduce the risk of hypothermia, which is a very re...
...ociation rapid access journal report: , , Study h... the ambulance,s arrival on the scene was similar ...men began after ambulances arrived and continued u... heart conditions may not be recognized as readily...
...ins April 11, 2011, with $8.05 Conversion Price ... CDIC ), the innovator and leader of BioZ(R) imped...d that the Company,s note holders had not exercise... the holders had an opportunity to elect, in Janua...
Other Medicine News:Health News:APHA Releases Public Health Priorities for New Congress and Administration 2Health News:Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race 2Health News:Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race 3Health News:Study uses bone marrow stem cells to regenerate skin 2Health News:Department of Health Urges Pennsylvanians to Prepare For Dangerously Cold Weather 2Health News:Women May Be More Likely to Experience EMS Delays for Heart Care 2Health News:Women May Be More Likely to Experience EMS Delays for Heart Care 3Health News:CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities 2
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...roscopic condenser humidifiers (HCH) capture the p... in the inspired gas. Small and compact, they are ...groscopic benefits. Depending on the tidal volume ...ume model., ,The adult HCH is ideal for patient t...
Medicine Products: